madinamerica.com /1 month ago

Psychiatric Drugs and Violence: What Can Genetics Tell Us? A Conversation With Selma Eikelenboom

Brooke Siem speaks with Selma Eikelenboom, together they explore what questions her research raises about the relationship between psychoactive drugs, genetic variation, and violen...

Read source
psychologytoday.com /1 month ago

The Real Problem With Psychiatric Prescribing Is the Order

Half of the kids who were started on antipsychotics for ADHD never tried a stimulant first. The fix is better sequencing, with deprescribing running in reverse.

Read source
nytimes.com /3 weeks ago

Antidepressants Don’t Correct A Chemical Imbalance. How, Then, Do They Work?

Here’s how psychiatrists like me think about the most promising hypotheses.

Read source
kevinmd.com /1 month ago

Why antipsychotics for depression need physician oversight

Atypical antipsychotics have quietly migrated from inpatient psychiatry to primary care offices, urgent care clinics, and telemedicine platforms staffed increasingly by nurse pract...

Read source
scitechdaily.com /3 weeks ago

Scientists Separate Psilocybin’s Brain-Rewiring Power From Its Hallucinations

Mouse experiments suggest psilocybin’s ability to rebuild brain connections may be separable from its psychedelic effects, opening new possibilities for non-hallucinogenic psychiat...

Read source
bioengineer.org /2 weeks ago

Outpatient Psychiatrists Weigh Relapse Risk Against Patient Wishes When Deprescribing Antipsychotics

A qualitative study of ten outpatient psychiatrists in Berlin and Brandenburg found that decisions about reducing or stopping antipsychotic medication are shaped by concepts of psy...

Read source
nytimes.com /1 week ago

New Research Compares Long-Term Relief From 21 Antidepressants

In the meta-analysis, a few drugs stood out for offering greater effectiveness over time.

Read source
cleveland.com /1 week ago

Scientists compared antidepressants over time. Three medications stood out

A major study of more than 30,000 people examined how well antidepressants work over the longer term. Researchers found escitalopram, duloxetine and agomelatine performed better th...

Read source
fodmapeveryday.com /4 weeks ago

New Research Identifies 3 Brain Pathways Linked to Long-Term Depression Relief

Scientists at the Icahn School of Medicine at Mount Sinai have identified three brain pathways associated with sustained improvement in patients receiving experimental treatment fo...

Read source
punchng.com /1 month ago

Student explores new treatments for depression, addiction

A Nigerian PhD candidate, Trust Nwaka, is researching how psychedelic drugs can be used to develop new treatments for depression and substance use disorder Read More: https://punc...

Read source
kevinmd.com /3 weeks ago

What pharmacogenetic testing can and can’t do in depression

More of my patients now arrive with a pharmacogenetic report, an ad promising to “end trial and error,” or an MTHFR result from an online forum. Others ask for a blood test or brai...

Read source
kevinmd.com /1 week ago

Why TMS targets now differ for depression, OCD, and anxiety

For most of its history, psychiatry has treated the brain as a chemical soup, adjusting neurotransmitters and waiting weeks to see whether anything changed. Transcranial magnetic s...

Read source
nltimes.nl /1 week ago

Study: Three antidepressants beat fluoxetine, active ingredient in Prozac, in long term

Research by Radbound University Medical Center analyzing 21 antidepressants showed that escitalopra

Read source
sciencedaily.com /2 days ago

A study of 30,000 people reveals which antidepressants may work best

A major review involving more than 30,000 people found that three antidepressants, including Lexapro and Cymbalta, may be more effective than Prozac at maintaining improvements in...

Read source
labiotech.eu /5 days ago

CNS drug discovery: How AI-powered EEG profiling can sharpen go/no-go decisions

Learn how quantitative EEG and AI give CNS drug discovery teams the evidence to progress or drop candidates before costly later-stage studies. The post CNS drug discovery: How AI-p...

Read source
kevinmd.com /1 month ago

Precision psychiatry clinics are outrunning the evidence

In the same week this October, two announcements promised to bring brain science into the psychiatrist’s office. In Shanghai, doctors described China’s first psychiatric brain-comp...

Read source
scitechdaily.com /1 day ago

A Major Review Reveals Three Antidepressants That May Outperform Prozac

A massive review of 30,000 people suggests three antidepressants may outperform Prozac, but the findings reveal how much remains unknown about long-term depression treatment. A new...

Read source
sciencedaily.com /1 month ago

Scientists uncover 3 key brain pathways linked to lasting depression relief

Researchers have uncovered three brain pathways linked to lasting improvements in people receiving deep brain stimulation for severe, treatment-resistant depression. They also disc...

Read source
madinamerica.com /1 month ago

Four New Studies Raise Concerns About Benzodiazepine-Related Harms

This week, Mad in America examines four new studies around harms linked to benzodiazepine use. The first finds that benzodiazepines are linked to increased risk of heart failure an...

Read source
fodmapeveryday.com /1 month ago

Scientists Discover 5 Distinct Brain Patterns That May Explain Why Depression Affects People Differently

Scientists at the University of Helsinki have discovered five distinct patterns of brain activity among people diagnosed with depression, revealing differences that extend beyond t...

Read source
madinamerica.com /1 month ago

From Efficacy to Non-Efficacy: Lessons from Pediatric Fluoxetine Trials 

Modern studies find that fluoxetine has lost its efficacy for children and can now be considered clinically equivalent to placebo. The post From Efficacy to Non-Efficacy: Lessons f...

Read source
psychedelicalpha.com /6 days ago

Breaking: Helus’ Deuterated Psilocin Hits Primary Endpoint in First Phase 3

This morning, Helus Pharma (formerly Cybin) announced a positive topline readout from its first Phase 3 study of HLP003, a deuterated psilocin analog, for the adjunctive treatment...

Read source
aljazeera.com /1 month ago

LSD – from counterculture to clinical trials

From psychiatric research to counterculture and secret CIA mind-control experiments, LSD makes its way back to the lab.

Read source
cbsnews.com /1 month ago

Doctor explains how GLP-1 drugs could help reduce gambling, shopping addiction

Dr. Carolina Haass-Koffler, associate professor of psychiatry at Brown University, joins "The Daily Report" to explain how GLP-1 drugs could be used to treat addictions beyond exce...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.